Re: Robert J. Motzer, Paul Russo, Naomi Haas, et al. Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients with Localized or Locally Advanced Renal Cell Carcinoma: Final Overall Survival Analysis of the Phase 3 PROTECT Trial. Eur Urol 2021;79:334–8: PROTECTing Patients with Locally Advanced Kidney Cancer

Nirmish Singla; Phillip Pierorazio; Mohamad Allaf; Yasser Ged

doi:10.1016/j.eururo.2021.04.025

Re: Robert J. Motzer, Paul Russo, Naomi Haas, et al. Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients with Localized or Locally Advanced Renal Cell Carcinoma: Final Overall Survival Analysis of the Phase 3 PROTECT Trial. Eur Urol 2021;79:334–8: PROTECTing Patients with Locally Advanced Kidney Cancer

Nirmish Singla, Phillip Pierorazio, Mohamad Allaf, Yasser Ged

School of Medicine

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	e33-e34
Journal	European Urology
Volume	80
Issue number	1
DOIs	https://doi.org/10.1016/j.eururo.2021.04.025
State	Published - Jul 2021

ASJC Scopus subject areas

Urology

Access to Document

10.1016/j.eururo.2021.04.025

Cite this

Singla, N., Pierorazio, P., Allaf, M., & Ged, Y. (2021). Re: Robert J. Motzer, Paul Russo, Naomi Haas, et al. Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients with Localized or Locally Advanced Renal Cell Carcinoma: Final Overall Survival Analysis of the Phase 3 PROTECT Trial. Eur Urol 2021;79:334–8: PROTECTing Patients with Locally Advanced Kidney Cancer. European Urology, 80(1), e33-e34. https://doi.org/10.1016/j.eururo.2021.04.025

Re: Robert J. Motzer, Paul Russo, Naomi Haas, et al. Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients with Localized or Locally Advanced Renal Cell Carcinoma: Final Overall Survival Analysis of the Phase 3 PROTECT Trial. Eur Urol 2021;79:334–8: PROTECTing Patients with Locally Advanced Kidney Cancer. / Singla, Nirmish; Pierorazio, Phillip; Allaf, Mohamad et al.
In: European Urology, Vol. 80, No. 1, 07.2021, p. e33-e34.

Research output: Contribution to journal › Letter › peer-review

Singla, N, Pierorazio, P, Allaf, M & Ged, Y 2021, 'Re: Robert J. Motzer, Paul Russo, Naomi Haas, et al. Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients with Localized or Locally Advanced Renal Cell Carcinoma: Final Overall Survival Analysis of the Phase 3 PROTECT Trial. Eur Urol 2021;79:334–8: PROTECTing Patients with Locally Advanced Kidney Cancer', European Urology, vol. 80, no. 1, pp. e33-e34. https://doi.org/10.1016/j.eururo.2021.04.025

Singla N, Pierorazio P, Allaf M , Ged Y. Re: Robert J. Motzer, Paul Russo, Naomi Haas, et al. Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients with Localized or Locally Advanced Renal Cell Carcinoma: Final Overall Survival Analysis of the Phase 3 PROTECT Trial. Eur Urol 2021;79:334–8: PROTECTing Patients with Locally Advanced Kidney Cancer. European Urology. 2021 Jul;80(1):e33-e34. doi: 10.1016/j.eururo.2021.04.025

Singla, Nirmish ; Pierorazio, Phillip ; Allaf, Mohamad et al. / Re : Robert J. Motzer, Paul Russo, Naomi Haas, et al. Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients with Localized or Locally Advanced Renal Cell Carcinoma: Final Overall Survival Analysis of the Phase 3 PROTECT Trial. Eur Urol 2021;79:334–8: PROTECTing Patients with Locally Advanced Kidney Cancer. In: European Urology. 2021 ; Vol. 80, No. 1. pp. e33-e34.

@article{d9adebb3df064e8599b16ea1c2e5e0be,

title = "Re: Robert J. Motzer, Paul Russo, Naomi Haas, et al. Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients with Localized or Locally Advanced Renal Cell Carcinoma: Final Overall Survival Analysis of the Phase 3 PROTECT Trial. Eur Urol 2021;79:334–8: PROTECTing Patients with Locally Advanced Kidney Cancer",

author = "Nirmish Singla and Phillip Pierorazio and Mohamad Allaf and Yasser Ged",

year = "2021",

month = jul,

doi = "10.1016/j.eururo.2021.04.025",

language = "English (US)",

volume = "80",

pages = "e33--e34",

journal = "European Urology",

issn = "0302-2838",

publisher = "Elsevier B.V.",

number = "1",

}

TY - JOUR

T1 - Re

T2 - Robert J. Motzer, Paul Russo, Naomi Haas, et al. Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients with Localized or Locally Advanced Renal Cell Carcinoma: Final Overall Survival Analysis of the Phase 3 PROTECT Trial. Eur Urol 2021;79:334–8: PROTECTing Patients with Locally Advanced Kidney Cancer

AU - Singla, Nirmish

AU - Pierorazio, Phillip

AU - Allaf, Mohamad

AU - Ged, Yasser

PY - 2021/7

Y1 - 2021/7

UR - http://www.scopus.com/inward/record.url?scp=85106581152&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85106581152&partnerID=8YFLogxK

U2 - 10.1016/j.eururo.2021.04.025

DO - 10.1016/j.eururo.2021.04.025

M3 - Letter

C2 - 33962807

AN - SCOPUS:85106581152

SN - 0302-2838

VL - 80

SP - e33-e34

JO - European Urology

JF - European Urology

IS - 1

ER -

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this